FeetSee thermal images for people with diabetes who have healed plantar ulcers
Official title: Foot Temperature and Diabetic Foot Ulcer Risk: Using the FeetSee Device to Generate a Unique Foot Temperature Dataset.
Run by Diabetis JSC · NCT07300163 · Data updated 2026-11-12
This study tests if using a FeetSee thermal camera with a smartphone can help people with diabetes who had a healed plantar ulcer catch early signs of trouble at the bottom of the feet.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 100 (estimated) |
| Sponsor | Diabetis JSC Industry-sponsored |
| Locations | 4 sites (Vilnius and 3 other locations) |
| Status | Recruiting |
| Started | December 16, 2025 |
| Main results expected | May 30, 2027 |
| Study ends | May 30, 2027 |
| Registry record updated | June 22, 2026 |
| Trial ID | NCT07300163 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults with type 1 or type 2 diabetes, a history of plantar DFU healed for at least 6 weeks, documented peripheral neuropathy, and at least one palpable foot pulse.
✕Probably not a fit
Patients without neuropathy, with active foot ulcers, or with severe vascular disease may not benefit from this monitoring approach.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This is a prospective, observational study enrolling adults with type 1 or type 2 diabetes and a recently healed plantar diabetic foot ulcer, who also have neuropathy. Participants use a FeetSee thermal camera attached to their own device to take daily plantar foot images at home, with data securely uploaded for analysis. The study aims to identify temperature patterns that may precede ulceration and to evaluate the feasibility and adherence of home-based thermal imaging in this population. Recruitment occurs at hospital sites in the UK and Lithuania, with follow-up through device support and periodic check-ins. Key exclusions include active ulcers, Charcot disease, severe vascular disease, or other conditions that would hinder safe device use.
Why it matters
Potential benefit: If successful, this approach could enable earlier detection of foot problems and prompt preventative actions to reduce ulcers and related complications.
How similar studies have gone: Previous research suggests thermal imaging can help detect inflammatory hotspots, but large-scale validation for ulcer prevention remains limited and this protocol is among early prospective observational efforts.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Males/females aged over 18 years. * Type 1 or type 2 diabetes. * History of plantar diabetic foot ulcer(s). * Foot ulcer healed for at least 6 weeks before entry into study, as determined by a specialist healthcare provider. * Presence of diabetic peripheral neuropathy defined by either of the following: * Inability to detect the monofilament (10g) applied at two foot sites, including the apex of the Hallux (ADA guidelines 2008 Diabetes Care 31(1)). * A Vibration Perception Threshold (VPT) \>20V, and/or by inability to detect application of the monofilament at the apex of the Hallux. * Presence of at least one palpable foot pulse. Exclusion Criteria: * Active foot ulceration. * Active Charcot neuro-osteoarthropathy. * Severe vascular disease (complete absence of any foot pulses). * Lower limb/foot amputation greater than metatarsophalangeal disarticulation. * Active malignancy, immunosuppressive disease. * Physical or mental condition(s) that limit the ability to follow instructions for the study, based on clinical judgment by the physician, such as inability to use the device without assistance. * Current participation in another clinical investigation of a medical device that is contraindicated for either study procedure/outcome.
Where it's running
-
Vilnius University Hospital Santaros Klinikos
Vilnius, Lithuania Recruiting -
Manchester University NHS Foundation Trust (MFT)
Manchester, United Kingdom Recruiting -
Blackpool Teaching Hospitals NHS Trust
Blackpool, United Kingdom Not yet recruiting -
Lancashire Teaching Hospitals NHS Foundation Trust
Lancaster, United Kingdom Not yet recruiting
Study contacts
- Principal investigator: Neil Reeves, Prof, Phd — Manchester University NHS Foundation Trust (MFT)
- Study coordinator: Helena Grinberg Rashi, Phd
- Email: helena@diabetis.lt
- Phone: +31615636666
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
BIOxHEAL plus standard care for nonhealing diabetic foot ulcers
A multicenter study tests whether applying BIOxHEAL, a placental-derived biologic, to stubborn diabetic foot ulcers helps more people heal when added to standard wound care.
-
Calcaneal Bone Marrow Cells in Foot/Ankle Surgery Patients
This observational study tests whether routine preoperative blood tests relate to the quality and behavior of mesenchymal stem cells from calcaneal bone marrow in adults undergoing foot or ankle surgery.
-
L-Carnitine as an add-on for healing diabetic foot ulcers
This study tests whether taking L-Carnitine helps wound healing in adults with diabetic foot ulcers, alongside standard diabetes and wound care.
-
THERAVEX Tissue Care Spray Plus for Healing of Skin Wounds and Ulcers
This observational review tests whether THERAVEX Tissue Care Spray Plus, used with standard wound care, helps heal various skin wounds and chronic ulcers in adults.
-
Pulsating electromagnetic field therapy for diabetic foot ulcers
This trial tests whether a PEMF device called CRAD ULCER X-01 helps heal chronic diabetic foot ulcers when added to standard wound care.
-
Transverse tibial bone transport to help heal chronic diabetic foot ulcers
This study tests a surgical approach called transverse tibial bone transport to see if it can help heal long‑lasting diabetic foot ulcers and prevent limb loss in adults with limited treatment options.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.